Prostaglandin D₂ in the skinIKAI, K; IMAMURA, S.International journal of dermatology. 1988, Vol 27, Num 3, pp 141-149, issn 0011-9059Article

The biology and pharmacology of PGD₂GILES, H; LEFF, P.Prostaglandins. 1988, Vol 35, Num 2, pp 277-300, issn 0090-6980Article

Absorption, metabolism, and excretion of [¹⁴C]MK-0524, a prostaglandin D₂ receptor antagonist, in humansKARANAM, Bindhu; MADEIRA, Maria; GARRETT, Graigory et al.Drug metabolism and disposition. 2007, Vol 35, Num 7, pp 1196-1202, issn 0090-9556, 7 p.Article

Identification and characterization of two nuclear factor-κB sites in the regulatory region of the dopamine D2 receptorBONTEMPI, Sandra; FIORENTINI, Chiara; BUSI, Chiara et al.Endocrinology (Philadelphia). 2007, Vol 148, Num 5, pp 2563-2570, issn 0013-7227, 8 p.Article

Putative mechanism of the itch-scratch circle : Repeated scratching decreases the cutaneous level of prostaglandin D₂, a mediator that inhibits itchingSUGIMOTO, Masanori; ARAI, Iwao; FUTAKI, Nobuko et al.Prostaglandins, leukotrienes and essential fatty acids. 2007, Vol 76, Num 2, pp 93-101, issn 0952-3278, 9 p.Article

Association of DRD2 gene variant with schizophreniaKUKRETI, Ritushree; TRIPATHI, Sudipta; BHATNAGAR, Pallav et al.Neuroscience letters. 2006, Vol 392, Num 1-2, pp 68-71, issn 0304-3940, 4 p.Article

¹²⁵I-spiperone: a novel ligand for D₂ dopamine receptorsGUNDLACH, A. L; LARGENT, B. L; SNYDER, S. H et al.Life sciences (1973). 1984, Vol 35, Num 19, pp 1981-1988, issn 0024-3205Article

Dopamine D₂ receptor subtypes couple to different second messenger systemsTODD, R. D; MACK, K. J; GANDELMAN, K.-Y et al.Neurochemistry international. 1992, Vol 20, Num MAR, pp 23S-26S, issn 0197-0186, SUPConference Paper

Influence of the dopamine D₂ receptor (DRD2) exon 8 genotype on efficacy of tiapride and clinical outcome of alcohol withdrawalLUCHT, Michael J; KUEHN, Kail U; FREYBERGER, Harald J et al.Pharmacogenetics (London). 2001, Vol 11, Num 8, pp 647-653, issn 0960-314XArticle

The effect of prostaglandin D₂ on angiotensin converting enzymeRAO, P. S; CAVANAGH, D; O'BRIEN, W. F et al.Prostaglandins, leukotrienes and essential fatty acids. 1988, Vol 33, Num 2, pp 111-114, issn 0952-3278Article

Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D₂ receptor subtype 1LAI, E; DE LEPELEIRE, I; CRUMLEY, T. M et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 6, pp 849-857, issn 0009-9236, 9 p.Article

Solubilization of dopamine-D₂receptors from synaptosomal membranes of the bovine caudate nucleusKIDRIC, M; PETROVIC, J; SOSKIC, V et al.British journal of pharmacology. 1984, Vol 83, Num 3, pp 687-695, issn 0007-1188Article

Quantification of thromboxane and PGD₂ metabolites in biological fluidsJACKSON ROBERTS II, L; OATES, J. A.Prostaglandins. 1984, Vol 27, Num 3, pp 352-354, issn 0090-6980Article

Decreased number of PGD₂ binding sites on platelets from patients with type IIa hyperlipoproteinemiaABBATE, R; MODESTI, P. A; FORTINI, A et al.Atherosclerosis. 1985, Vol 54, Num 2, pp 167-175, issn 0021-9150Article

The opposing role of two prostaglandin D₂ receptors, DP and CRTH2, in human eosinophil migrationCHIBA, Takahito; UEKI, Shigeharu; ITO, Wataru et al.Annals of allergy, asthma, & immunology. 2011, Vol 106, Num 6, pp 511-517, issn 1081-1206, 7 p.Article

THE GENETICS OF SCHIZOPHRENIABERTOLINO, A; BLASI, G.Neuroscience. 2009, Vol 164, Num 1, pp 288-299, issn 0306-4522, 12 p.Article

Prostaglandin D₂ pathway and peroxisome proliferator-activated receptor γ-1 expression are induced by mechanical loading in an osteoblastic cell lineSIDDHIVARN, Chitpol; BANES, Albert; CHAMPAGNE, Catherine et al.Journal of periodontal research. 2006, Vol 41, Num 2, pp 92-100, issn 0022-3484, 9 p.Article

PREVENTIVE EFFECT OF α-LIPOIC ACID ON PREPULSE INHIBITION DEFICITS IN A JUVENILE TWO-HIT MODEL OF SCHIZOPHRENIADESLAURIERS, J; RACINE, W; SARRET, P et al.Neuroscience. 2014, Vol 272, pp 261-270, issn 0306-4522, 10 p.Article

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patchJOHNSTONE, Elaine C; YUDKIN, Patricia L; HEY, Kate et al.Pharmacogenetics (London). 2004, Vol 14, Num 2, pp 83-90, issn 0960-314X, 8 p.Article

Inverse agonist properties of atypical antipsychotic drugsAKAM, Elizabeth; STRANGE, Philip G.Biochemical pharmacology. 2004, Vol 67, Num 11, pp 2039-2045, issn 0006-2952, 7 p.Article

Hyperactivity to novelty induced by social isolation is not correlated with changes in D2 receptor function and binding in striatumDEL ARCO, Alberto; SHUNWEI ZHU; TERASMAA, Anton et al.Psychopharmacologia. 2004, Vol 171, Num 2, pp 148-155, issn 0033-3158, 8 p.Article

The Taq IA and Ser311Cys polymorphisms in the dopamine D2 receptor gene and obesitySOUTHON, A; WALDER, K; SANIGORSKI, A. M et al.Diabetes, nutrition & metabolism (Testo stampato). 2003, Vol 16, Num 1, pp 72-76, issn 0394-3402, 5 p.Article

Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D₂ ProductionBUTTERFIELD, Joseph H; WEILER, Catherine R.International archives of allergy and immunology. 2008, Vol 147, Num 4, pp 338-343, issn 1018-2438, 6 p.Article

The dopamine receptor D₂ genotype is associated with hyperprolactinemiaHANSEN, Keith A; YUEYI ZHANG; COLVER, Robert et al.Fertility and sterility. 2005, Vol 84, Num 3, pp 711-718, issn 0015-0282, 8 p.Conference Paper

Investigation of the mechanism of agonist and inverse agonist action at D₂ dopamine receptorsROBERTS, David J; HONG LIN; STRANGE, Philip G et al.Biochemical pharmacology. 2004, Vol 67, Num 9, pp 1657-1665, issn 0006-2952, 9 p.Article